Pengpeng Liu
- Aging top 1%
- Genetics, Aging, and Longevity in Model Organisms 7
- Molecular Biology top 5%
- CRISPR and Genetic Engineering 21
- RNA modifications and cancer 7
- RNA and protein synthesis mechanisms 5
- RNA regulation and disease 5
- Epigenetics and DNA Methylation 5
- Cancer Research top 10%
- Cancer-related molecular mechanisms research 8
- MicroRNA in disease regulation 5
- Genetics top 10%
- Co-authors
- Scot A. WolfeErik J. SontheimerWen XueLihua Julie ZhuShun‐Qing LiangKarthikeyan PonnienselvanAamir MirEsther Mintzer
- Partner nations
- ChinaUnited StatesCanada
In The Last Decade
Pengpeng Liu
51 papers receiving 1.6k citations
Hit Papers
Peers
Comparison fields: 5 of 100
- Aging 211
- Business and International Management 119
- Molecular Biology 1.4k
- Cancer Research 265
- Genetics 281
Countries citing papers authored by Pengpeng Liu
This map shows the geographic impact of Pengpeng Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pengpeng Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pengpeng Liu more than expected).
Fields of papers citing papers by Pengpeng Liu
This network shows the impact of papers produced by Pengpeng Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pengpeng Liu. The network helps show where Pengpeng Liu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Pengpeng Liu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 2 | |
| 3 | 2023 | 34 | |
| 4 | 2023 | 43 | |
| 5 | 2022 | 59 | |
| 6 | 2022 | 34 | |
| 7 | 2022 | 25 | |
| 8 | 2022 | 43 | |
| 9 | 2022 | 16 | |
| 10 | 2022 | 9 | |
| 11 | 2021 | 73 | |
| 12 | 2021 | 38 | |
| 13 | 2021 | 23 | |
| 14 | Improved prime editors enable pathogenic allele correction and cancer modelling in adult micebreakdown → | 2021 | 196 |
| 15 | 2021 | 11 | |
| 16 | 2020 | 43 | |
| 17 | 2018 | 48 | |
| 18 | 2018 | 79 | |
| 19 | 2018 | 96 | |
| 20 | Effect of PCR amplification with nano-silver on DNA synthesis and its mechanism. | 2010 | 2 |
About Pengpeng Liu
Pengpeng Liu is a scholar working on Aging, Cancer Research and Molecular Biology, having authored 53 papers that have together received 1.6k indexed citations. Recurring topics across this work include CRISPR and Genetic Engineering (21 papers), Cancer-related molecular mechanisms research (8 papers), Genetics, Aging, and Longevity in Model Organisms (7 papers), RNA modifications and cancer (7 papers), MicroRNA in disease regulation (5 papers), RNA and protein synthesis mechanisms (5 papers), RNA regulation and disease (5 papers) and Epigenetics and DNA Methylation (5 papers). The work is most often cited by research in Aging (211 citations), Business and International Management (119 citations) and Molecular Biology (1.4k citations). Pengpeng Liu has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Scot A. Wolfe, Erik J. Sontheimer, Wen Xue, Lihua Julie Zhu, Shun‐Qing Liang, Karthikeyan Ponnienselvan, Aamir Mir, Esther Mintzer, Zhisu Liu and Raed Ibraheim. Their work appears in journals such as Nature, Nucleic Acids Research and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.